Diverse cellular and physiological roles of phospholipase C-γ1

Advances in Biological Regulation

Volumn 52, Issue 1, 2012, Pages 138-151

  Yang, Yong Ryoul ^a,b   Choi, Jang Hyun ^c   Chang, Jong Soo ^d   Kwon, H Moo ^a   Jang, Hyun Jun ^a,b   Ryu, Sung Ho ^b   Suh, Pann Ghill ^a  

^a Ulsan National Institute of Science and Technology   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d Daejin University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84865649744     PISSN: 22124926     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.advenzreg.2011.09.017     Document Type: Article

References (137)

1. Aguado E., Richelme S., Nunez-Cruz S., Miazek A., Mura A.M., Richelme M., et al. Induction of T helper type 2 immunity by a point mutation in the LAT adaptor. Science 2002, 296:2036-2040.
2. Alimandi M., Heidaran M.A., Gutkind J.S., Zhang J.C., Ellmore N., Valius M., et al. PLC-gamma activation is required for PDGF-beta R-mediated mitogenesis and monocytic differentiation of myeloid progenitor cells. Oncogene 1997, 15:585-593.
3. Arteaga C.L., Johnson M.D., Todderud G., Coffey R.J., Carpenter G., Page D.L. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas. Proc Natl Acad Sci U S A 1991, 88:10435-10439.
4. Asemu G., Tappia P.S., Dhalla N.S. Identification of the changes in phospholipase C isozymes in ischemic-reperfused rat heart. Arch Biochem Biophys 2003, 411:174-182.
5. 2+-permeable channels in the hepatocyte plasma membrane and their roles in hepatocyte physiology. Biochim Biophys Acta - Mol Cell Res 2008, 1783:651-672.
6. 2+ channels in liver cells. Biochem J 2007, 405:269-276.
7. Berridge M.J., Irvine R.F. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984, 312:315-321.
8. Bolanos C.A., Neve R.L., Nestler E.J. Phospholipase C gamma in distinct regions of the ventral tegmental area differentially regulates morphine-induced locomotor activity. Synapse 2005, 56:166-169.
9. Bolanos C.A., Perrotti L.I., Edwards S., Eisch A.J., Barrot M., Olson V.G., et al. Phospholipase Cgamma in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J Neurosci 2003, 23:7569-7576.
10. Bornfeldt K.E., Raines E.W., Nakano T., Graves L.M., Krebs E.G., Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994, 93:1266-1274.
11. Broad L.M., Braun F.J., Lievremont J.P., Bird G.S., Kurosaki T., Putney J.W. Role of the phospholipase C-inositol 1,4,5-trisphosphate pathway in calcium release-activated calcium current and capacitative calcium entry. J Biol Chem 2001, 276:15945-15952.
12. Burg M.B., Ferraris J.D., Dmitrieva N.I. Cellular response to hyperosmotic stresses. Physiol Rev 2007, 87:1441-1474.
13. Cao Y., Li H., Liu H., Zhang M., Hua Z., Ji H., et al. LKB1 regulates TCR-mediated PLCgamma1 activation and thymocyte positive selection. EMBO J 2011, 30:2083-2093.
14. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395.
15. Carpenter G., Ji Q.S. Phospholipase C-gamma as a signal-transducing element. Exp Cell Res 1999, 253:15-24.
16. Chang J.S., Chung S.H., Kim S.K., Kim J.K., Yang Y.R., Suh P.G. A double point mutation in PCL-gamma 1 (Y509A/F510A) enhances Y783 phosphorylation and inositol phospholipid-hydrolyzing activity upon EGF stimulation. Exp Mol Med 2010, 42:216-222.
17. Chang J.S., Kim S.K., Kwon T.K., Bae S.S., Min D.S., Lee Y.H., et al. Pleckstrin homology domains of phospholipase C-gamma1 directly interact with beta-tubulin for activation of phospholipase C-gamma1 and reciprocal modulation of beta-tubulin function in microtubule assembly. J Biol Chem 2005, 280:6897-6905.
18. Chang J.S., Seok H., Kwon T.K., Min D.S., Ahn B.H., Lee Y.H., et al. Interaction of elongation factor-1alpha and pleckstrin homology domain of phospholipase C-gamma 1 with activating its activity. J Biol Chem 2002, 277:19697-19702.
19. Chattopadhyay A., Vecchi M., Ji Q., Mernaugh R., Carpenter G. The role of individual SH2 domains in mediating association of phospholipase C-gamma1 with the activated EGF receptor. J Biol Chem 1999, 274:26091-26097.
20. Chen P., Xie H., Sekar M.C., Gupta K., Wells A. Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement. J Cell Biol 1994, 127:847-857.
21. Choi J.H., Kim H.S., Kim S.H., Yang Y.R., Bae Y.S., Chang J.S., et al. Phospholipase Cgamma1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B. Nat Cell Biol 2006, 8:1389-1397.
22. Choi J.H., Park J.B., Bae S.S., Yun S., Kim H.S., Hong W.P., et al. Phospholipase C-gamma 1 is a guanine nucleotide exchange factor for dynamin-1 and enhances dynamin-1-dependent epidermal growth factor receptor endocytosis. J Cell Sci 2004, 117:3785-3795.
23. Choi J.H., Ryu S.H., Suh P.G. On/off-regulation of phospholipase C-gamma 1-mediated signal transduction. Adv Enz Regul 2007, 47:104-116.
24. Choi J.H., Yang Y.R., Lee S.K., Kim I.S., Ha S.H., Kim E.K., et al. Phospholipase C-gamma1 potentiates integrin-dependent cell spreading and migration through Pyk2/paxillin activation. Cell Signal 2007, 19:1784-1796.
25. Derman M.P., Chen J.Y., Spokes K.C., Songyang Z., Cantley L.G. An 11-amino acid sequence from c-met initiates epithelial chemotaxis via phosphatidylinositol 3-kinase and phospholipase C. J Biol Chem 1996, 271:4251-4255.
26. Ebinu J.O., Stang S.L., Teixeira C., Bottorff D.A., Hooton J., Blumberg P.M., et al. RasGRP links T-cell receptor signaling to Ras. Blood 2000, 95:3199-3203.
27. Espagnolle N., Depoil D., Zaru R., Demeur C., Champagne E., Guiraud M., et al. CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse. Int Immunol 2007, 19:239-248.
28. Falasca M., Sala G., Dituri F., Raimondi C., Previdi S., Maffucci T., et al. Phospholipase C gamma 1 Is required for metastasis development and progression. Cancer Res 2008, 68:10187-10196.
29. Fishman M.C., Rottbauer W., Just S., Wessels G., Trano N., Most P., et al. VEGF-PLC gamma 1 pathway controls cardiac contractility in the embryonic heart. Gene Dev 2005, 19:1624-1634.
30. Ftouhi-Paquin N., Alda M., Grof P., Chretien N., Rouleau G., Turecki G. Identification of three polymorphisms in the translated region of PLC-gamma 1 and their investigation in lithium responsive bipolar disorder. Am J Med Genet 2001, 105:301-305.
31. Graham L.J., Stoica B.A., Shapiro M., DeBell K.E., Rellahan B., Laborda J., et al. Sequences surrounding the Src-homology 3 domain of phospholipase C gamma-1 increase the domain's association with Cbl. Biochem Biophys Res Commun 1998, 249:537-541.
32. Hains D., Sims-Lucas S., Kish K., Saha M., McHugh K., Bates C.M. Role of fibroblast growth factor receptor 2 in kidney mesenchyme. Pediatr Res 2008, 64:592-598.
33. Hashimoto A., Takeda K., Inaba M., Sekimata M., Kaisho T., Ikehara S., et al. Cutting edge: essential role of phospholipase C-gamma 2 in B cell development and function. J Immunol 2000, 165:1738-1742.
34. Homma Y., Takenawa T., Emori Y., Sorimachi H., Suzuki K. Tissue- and cell type-specific expression of mRNAs for four types of inositol phospholipid-specific phospholipase C. Biochem Biophys Res Commun 1989, 164:406-412.
35. Huang E.J., Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 2003, 72:609-642.
36. Ihle J.N., Wang D.M., Feng J., Wen R.R., Marine J.C., Sangster M.Y., et al. Phospholipase C gamma 2 is essential in the functions of B cell and several Fc receptors. Immunity 2000, 13:25-35.
37. Irarrazabal C.E., Gallazzini M., Schnetz M.P., Kunin M., Simons B.L., Williams C.K., et al. Phospholipase C-gamma1 is involved in signaling the activation by high NaCl of the osmoprotective transcription factor TonEBP/OREBP. Proc Natl Acad Sci U S A 2010, 107:906-911.
38. Irvin B.J., Williams B.L., Nilson A.E., Maynor H.O., Abraham R.T. Pleiotropic contributions of phospholipase C-gamma1 (PLC-gamma1) to T-cell antigen receptor-mediated signaling: reconstitution studies of a PLC-gamma1-deficient Jurkat T-cell line. Mol Cell Biol 2000, 20:9149-9161.
39. 2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells. Carcinogenesis 1988, 9:1033-1038.
40. Ji Q.S., Ermini S., Baulida J., Sun F.L., Carpenter G. Epidermal growth factor signaling and mitogenesis in Plcg1 null mouse embryonic fibroblasts. Mol Biol Cell 1998, 9:749-757.
41. Ji Q.S., Winnier G.E., Niswender K.D., Horstman D., Wisdom R., Magnuson M.A., et al. Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development. Proc Natl Acad Sci U S A 1997, 94:2999-3003.
42. Jones N.P., Katan M. Role of phospholipase Cgamma1 in cell spreading requires association with a beta-Pix/GIT1-containing complex, leading to activation of Cdc42 and Rac1. Mol Cell Biol 2007, 27:5790-5805.
43. Kamat A., Carpenter G. Phospholipase C-gamma1: regulation of enzyme function and role in growth factor-dependent signal transduction. Cytokine Growth Factor Rev 1997, 8:109-117.
44. Kassis J., Moellinger J., Lo H., Greenberg N.M., Kim H.G., Wells A. A role for phospholipase C-gamma-mediated signaling in tumor cell invasion. Clin Cancer Res 1999, 5:2251-2260.
45. Katan M. Families of phosphoinositide-specific phospholipase C: structure and function. Biochim Biophys Acta 1998, 1436:5-17.
46. Katan M., Jones N.P., Peak J., Brader S., Eccles S.A. PLC gamma 1 is essential for early events in integrin signalling required for cell motility. J Cell Sci 2005, 118:2695-2706.
47. Kayali A.G., Eichhorn J., Haruta T., Morris A.J., Nelson J.G., Vollenweider P., et al. Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin. J Biol Chem 1998, 273:13808-13818.
48. Kim H.K., Kim J.W., Zilberstein A., Margolis B., Kim J.G., Schlessinger J., et al. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-gamma 1 phosphorylation on tyrosine residues 783 and 1254. Cell 1991, 65:435-441.
49. Kim M.J., Chang J.S., Park S.K., Hwang J.I., Ryu S.H., Suh P.G. Direct interaction of SOS1 Ras exchange protein with the SH3 domain of phospholipase C-gamma1. Biochemistry 2000, 39:8674-8682.
50. Kim M.J., Kim E., Ryu S.H., Suh P.G. The mechanism of phospholipase C-gamma1 regulation. Exp Mol Med 2000, 32:101-109.
51. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron 1998, 21:467-476.
52. Koster M.I., Roop D.R. Mechanisms regulating epithelial stratification. Annu Rev Cell Dev Biol 2007, 23:93-113.
53. Kundra V., Escobedo J.A., Kazlauskas A., Kim H.K., Rhee S.G., Williams L.T., et al. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta. Nature 1994, 367:474-476.
54. Kurosaki T., Maeda A., Ishiai M., Hashimoto A., Inabe K., Takata M. Regulation of the phospholipase C-gamma2 pathway in B cells. Immunol Rev 2000, 176:19-29.
55. Kurosaki T., Okada T. Regulation of phospholipase C-gamma2 and phosphoinositide 3-kinase pathways by adaptor proteins in B lymphocytes. Int Rev Immunol 2001, 20:697-711.
56. Kwon Y.K., Jang H.J., Kole S., He H.J., Bernier M. Role of the pleckstrin homology domain of PLCgamma1 in its interaction with the insulin receptor. J Cell Biol 2003, 163:375-384.
57. Larose L., Gish G., Shoelson S., Pawson T. Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1. Oncogene 1993, 8:2493-2499.
58. Lawson N.D., Mugford J.W., Diamond B.A., Weinstein B.M. Phospholipase C gamma-1 is required downstream of vascular endothelial growth factor during arterial development. Genes Dev 2003, 17:1346-1351.
59. Lee R.H., Wong W.L., Chan C.H., Chan S.Y. Differential effects of glial cell line-derived neurotrophic factor and neurturin in RET/GFRalpha1-expressing cells. J Neurosci Res 2006, 83:80-90.
60. Li S., Wang Q., Wang Y., Chen X., Wang Z. PLC-gamma1 and Rac1 coregulate EGF-induced cytoskeleton remodeling and cell migration. Mol Endocrinol 2009, 23:901-913.
61. Liao H.J., Kume T., McKay C., Xu M.J., Ihle J.N., Carpenter G. Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice. J Biol Chem 2002, 277:9335-9341.
62. Lidofsky S.D., Moore A.L., Roe M.W., Melnick R.F. Calcium mobilization evoked by hepatocellular swelling is linked to activation of phospholipase C gamma. J Biol Chem 2002, 277:34030-34035.
63. Lin X., Wang D. The roles of CARMA1, Bcl10, and MALT1 in antigen receptor signaling. Semin Immunol 2004, 16:429-435.
64. Lorenzo M., Teruel T., Hernandez R., Kayali A.G., Webster N.J. PLCgamma participates in insulin stimulation of glucose uptake through activation of PKCzeta in brown adipocytes. Exp Cell Res 2002, 278:146-157.
65. Luo S.Q., Bai X.C., Deng F., Liu A.L., Zou Z.P., Wang Y., et al. Phospholipase C-gamma 1 is required for cell survival in oxidative stress by protein kinase C. Biochem J 2002, 363:395-401.
66. 2. Am J Physiol Heart Circ Physiol 2006, 291:H854-H860.
67. Marrero M.B., Paxton W.G., Schieffer B., Ling B.N., Bernstein K.E. Angiotensin II signalling events mediated by tyrosine phosphorylation. Cell Signal 1996, 8:21-26.
68. Martin T.A., Davies G., Ye L., Lewis-Russell J.A., Mason M.D., Jiang W.G. Phospholipase-C gamma-1 (PLC gamma-1) is critical in hepatocyte growth factor induced in vitro invasion and migration without affecting the growth of prostate cancer cells. Urol Oncol-Semin Ori 2008, 26:386-391.
69. Menon G.K., Grayson S., Elias P.M. Ionic calcium reservoirs in mammalian epidermis: ultrastructural localization by ion-capture cytochemistry. J Invest Dermatol 1985, 84:508-512.
70. Minichiello L., Calella A.M., Medina D.L., Bonhoeffer T., Klein R., Korte M. Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 2002, 36:121-137.
71. Minichiello L., Medina D.L., Sciarretta C., Calella A.M., von Bohlen und Halbach O., Unsicker K. TrkB regulates neocortex formation through the Shc/PLC gamma-mediated control of neuronal migration. Embo J 2004, 23:3803-3814.
72. Mizuguchi M., Yamada M., Kim S.U., Rhee S.G. Phospholipase C isozymes in neurons and glial cells in culture: an immunocytochemical and immunochemical study. Brain Res 1991, 548:35-40.
73. Mohammadi M., Dionne C.A., Li W., Li N., Spivak T., Honegger A.M., et al. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 1992, 358:681-684.
74. Mohammadi M., Honegger A.M., Rotin D., Fischer R., Bellot F., Li W., et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol 1991, 11:5068-5078.
75. Nakamura Y., Fukami K. Roles of phospholipase C isozymes in organogenesis and embryonic development. Physiology (Bethesda) 2009, 24:332-341.
76. Narita M., Ohnishi O., Aoki T., Suzuki M., Yajima Y., Funahashi H., et al. Direct evidence for the activation of phospholipase C gamma 1 by in vivo treatment with morphine in the mouse periaqueductal gray matter. Brain Res 2003, 970:140-148.
77. Nestler E.J., Aghajanian G.K. Molecular and cellular basis of addiction. Science 1997, 278:58-63.
78. Nishizuka Y. The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature 1988, 334:661-665.
79. Noh D.Y., Lee Y.H., Kim S.S., Kim Y.I., Ryu S.H., Suh P.G., et al. Elevated content of phospholipase C-gamma 1 in colorectal cancer tissues. Cancer 1994, 73:36-41.
80. Nomoto K., Tomita N., Miyake M., Xhu D.B., LoGerfo P.R., Weinstein I.B. Expression of phospholipases gamma 1, beta 1, and delta 1 in primary human colon carcinomas and colon carcinoma cell lines. Mol Carcinogen 1995, 12:146-152.
81. Park J.G., Lee Y.H., Kim S.S., Park K.J., Noh D.Y., Ryu S.H., et al. Overexpression of phospholipase C-gamma 1 in familial adenomatous polyposis. Cancer Res 1994, 54:2240-2244.
82. Patterson R.L., van Rossum D.B., Nikolaidis N., Gill D.L., Snyder S.H. Phospholipase C-gamma: diverse roles in receptor-mediated calcium signaling. Trends Biochem Sci 2005, 30:688-697.
83. Pawson T., Gish G.D. SH2 and SH3 domains: from structure to function. Cell 1992, 71:359-362.
84. Pawson T., Nash P. Protein-protein interactions define specificity in signal transduction. Genes Dev 2000, 14:1027-1047.
85. 2+ flux but not mitogenesis. Nature 1992, 358:678-681.
86. Piccolo E., Innominato P.F., Mariggio M.A., Maffucci T., Iacobelli S., Falasca M. The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration. Oncogene 2002, 21:6520-6529.
87. Pierce R.C., Kumaresan V. The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?. Neurosci Biobehav Rev 2006, 30:215-238.
88. Rao A., Luo C., Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997, 15:707-747.
89. Reiss M., Lipsey L.R., Zhou Z.L. Extracellular calcium-dependent regulation of transmembrane calcium fluxes in murine keratinocytes. J Cell Physiol 1991, 147:281-291.
90. Rhee S.G. Regulation of phosphoinositide-specific phospholipase C. Annu Rev Biochem 2001, 70:281-312.
91. Roche S., McGlade J., Jones M., Gish G.D., Pawson T., Courtneidge S.A. Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways. EMBO J 1996, 15:4940-4948.
92. Ronnstrand L., Mori S., Arridsson A.K., Eriksson A., Wernstedt C., Hellman U., et al. Identification of two C-terminal autophosphorylation sites in the PDGF beta-receptor: involvement in the interaction with phospholipase C-gamma. EMBO J 1992, 11:3911-3919.
93. Rotin D., Margolis B., Mohammadi M., Daly R.J., Daum G., Li N., et al. SH2 domains prevent tyrosine dephosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase C gamma. EMBO J 1992, 11:559-567.
94. - channels in rat hepatocytes. J Physiol-London 2006, 573:611-625.
95. Sakurai Y., Ohgimoto K., Kataoka Y., Yoshida N., Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci U S A 2005, 102:1076-1081.
96. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
97. Samelson L.E., Sommers C.L., Lee J., Steiner K.L., Gurson J.M., DePersis C.L., et al. Mutation of the phospholipase C-gamma 1-binding site of LAT affects both positive and negative thymocyte selection. J Exp Med 2005, 201:1125-1134.
98. Sawano A., Takahashi T., Yamaguchi S., Shibuya M. The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma. Biochem Biophys Res Commun 1997, 238:487-491.
99. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000, 103:211-225.
100. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994, 367:380-383.
101. Seedorf K., Kostka G., Lammers R., Bashkin P., Daly R., Burgess W.H., et al. Dynamin binds to SH3 domains of phospholipase C gamma and GRB-2. J Biol Chem 1994, 269:16009-16014.
102. Shepard C.R., Kassis J., Whaley D.L., Kim H.G., Wells A. PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene 2007, 26:3020-3026.
103. Shibuya M., Takahashi T., Yamaguchi S., Chida K. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. Embo J 2001, 20:2768-2778.
104. Shien T., Doihara H., Hara H., Takahashi H., Yoshitomi S., Taira N., et al. PLC and PI3K pathways are important in the inhibition of EGF-induced cell migration by gefitinib ('Iressa', ZD1839). Breast Cancer 2004, 11:367-373.
105. Shirane M., Sawa H., Kobayashi Y., Nakano T., Kitajima K., Shinkai Y., et al. Deficiency of phospholipase C-gamma1 impairs renal development and hematopoiesis. Development 2001, 128:5173-5180.
106. Smith M.R., Liu Y.L., Kim H., Rhee S.G., Kung H.F. Inhibition of serum- and ras-stimulated DNA synthesis by antibodies to phospholipase C. Science 1990, 247:1074-1077.
107. 2+ entry. Cell 2002, 111:529-541.
108. Sommers C.L. A LAT mutation that inhibits T cell development yet induces lymphoproliferation. Science 2002, 296:2040-2043.
109. Songyang Z., Shoelson S.E., Chaudhuri M., Gish G., Pawson T., Haser W.G., et al. SH2 domains recognize specific phosphopeptide sequences. Cell 1993, 72:767-778.
110. Sozzani P., Hasan L., Seguelas M.H., Caput D., Ferrara P., Pipy B., et al. IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production. Biochem Biophys Res Commun 1998, 244:665-670.
111. Suh P.G., Park J.I., Manzoli L., Cocco L., Peak J.C., Katan M., et al. Multiple roles of phosphoinositide-specific phospholipase C isozymes. BMB Rep 2008, 41:415-434.
112. Tanaka O., Kondo H. Localization of mRNAs for three novel members (beta 3, beta 4 and gamma 2) of phospholipase C family in mature rat brain. Neurosci Lett 1994, 182:17-20.
113. Tang W., Ziboh V.A., Isseroff R., Martinez D. Turnover of inositol phospholipids in cultured murine keratinocytes: possible involvement of inositol triphosphate in cellular differentiation. J Invest Dermatol 1988, 90:37-43.
114. Tu C.L., Chang W.H., Bikle D.D. Phospholipase C gamma 1 is required for activation of store-operated channels in human keratinocytes. J Invest Dermatol 2005, 124:187-197.
115. Turecki G., Grof P., Cavazzoni P., Duffy A., Grof E., Ahrens B., et al. Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder. Mol Psychiatry 1998, 3:534-538.
116. Tvorogov D., Carpenter G. EGF-dependent association of phospholipase C-gamma1 with c-Cbl. Exp Cell Res 2002, 277:86-94.
117. Ueno E., Haruta T., Uno T., Usui I., Iwata M., Takano A., et al. Potential role of Gab1 and phospholipase C-gamma in osmotic shock-induced glucose uptake in 3T3-L1 adipocytes. Horm Metab Res 2001, 33:402-406.
118. Valius M., Bazenet C., Kazlauskas A. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively. Mol Cell Biol 1993, 13:133-143.
119. Wang X.T., McCullough K.D., Wang X.J., Carpenter G., Holbrook N.J. Oxidative stress-induced phospholipase C-gamma 1 activation enhances cell survival. J Biol Chem 2001, 276:28364-28371.
120. Wang Z., Gluck S., Zhang L., Moran M.F. Requirement for phospholipase C-gamma1 enzymatic activity in growth factor-induced mitogenesis. Mol Cell Biol 1998, 18:590-597.
121. Wange R.L. LAT, the linker for activation of T cells: a bridge between T cell-specific and general signaling pathways. Sci STKE 2000, 2000: re1.
122. Webster N.J.G., Eichhorn J., Kayali A.G., Austin D.A. Insulin activates phospholipase C-gamma 1 via a PI-3 kinase dependent mechanism in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001, 282:615-620.
123. Wells A., Grandis J.R. Phospholipase C-gamma 1 in tumor progression. Clin Exp Metastas 2003, 20:285-290.
124. Wen R.R., Fu G.P., Chen Y.H., Yu M., Podd A., Schuman J., et al. Phospholipase C gamma 1 is essential for T cell development, activation, and tolerance. J Exp Med 2010, 207:309-318.
125. Wolf D.H., Nestler E.J., Russell D.S. Regulation of neuronal PLCgamma by chronic morphine. Brain Res 2007, 1156:9-20.
126. Xie Z., Bikle D.D. Phospholipase C-gamma1 is required for calcium-induced keratinocyte differentiation. J Biol Chem 1999, 274:20421-20424.
127. Xie Z., Bikle D.D. The recruitment of phosphatidylinositol 3-kinase to the E-cadherin-catenin complex at the plasma membrane is required for calcium-induced phospholipase C-gamma1 activation and human keratinocyte differentiation. J Biol Chem 2007, 282:8695-8703.
128. Xie Z., Peng J., Pennypacker S.D., Chen Y. Critical role for the catalytic activity of phospholipase C-gamma1 in epidermal growth factor-induced cell migration. Biochem Biophys Res Commun 2010, 399:425-428.
129. Xie Z., Singleton P.A., Bourguignon L.Y., Bikle D.D. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol Biol Cell 2005, 16:3236-3246.
130. Xie Z.J., Chen Y., Liao E.Y., Jiang Y., Liu F.Y., Pennypacker S.D. Phospholipase C-gamma 1 is required for the epidermal growth factor receptor-induced squamous cell carcinoma cell mitogenesis. Biochem Biophys Res Commun 2010, 397:296-300.
131. Xie Z.J., Chen Y., Pennypacker S.D., Zhou Z.G., Peng D. The SH3 domain, but not the catalytic domain, is required for phospholipase C-gamma 1 to mediate epidermal growth factor-induced mitogenesis. Biochem Biophys Res Commun 2010, 398:719-722.
132. Yablonski D., Kadlecek T., Weiss A. Identification of a phospholipase C-gamma1 (PLC-gamma1) SH3 domain-binding site in SLP-76 required for T-cell receptor-mediated activation of PLC-gamma1 and NFAT. Mol Cell Biol 2001, 21:4208-4218.
133. Ye K., Snyder S.H. PIKE GTPase: a novel mediator of phosphoinositide signaling. J Cell Sci 2004, 117:155-161.
134. Zhang Z., Pascuet E., Hueber P.A., Chu L., Bichet D.G., Lee T.C., et al. Targeted inactivation of EGF receptor inhibits renal collecting duct development and function. J Am Soc Nephrol 2010, 21:573-578.
135. Zhao H., Kegg H., Grady S., Truong H.T., Robinson M.L., Baum M., et al. Role of fibroblast growth factor receptors 1 and 2 in the ureteric bud. Dev Biol 2004, 276:403-415.
136. Zhou X., Izumi Y., Burg M.B., Ferraris J.D. Rac1/osmosensing scaffold for MEKK3 contributes via phospholipase C-{gamma}1 to activation of the osmoprotective transcription factor NFAT5. Proc Natl Acad Sci U S A 2011, 108:12155-12160.
137. Zirrgiebel U., Ohga Y., Carter B., Berninger B., Inagaki N., Thoenen H., et al. Characterization of TrkB receptor-mediated signaling pathways in rat cerebellar granule neurons: involvement of protein kinase C in neuronal survival. J Neurochem 1995, 65:2241-2250.